1800 202 8726
After a negative biopsy

Repeat Prostate Biopsy — After a Negative Result

A negative prostate biopsy does not always mean no cancer. Standard sampling can miss tumours in areas the needles did not reach — and if your PSA keeps rising, your urologist will consider whether and how to repeat the procedure.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Sampling error is real — A biopsy covers only a portion of the gland. A cancer between needle tracks will not be found even with a perfectly performed procedure.
  • Rising PSA is the main trigger — A PSA that keeps climbing after a negative result is the signal most likely to prompt your urologist to consider a repeat.
  • MRI changes the approach — Guidelines recommend a specialist MRI scan before any repeat, so needles are directed at suspicious areas rather than taken randomly.
  • The route may also change — Transperineal biopsy, where needles enter through skin rather than the rectal wall, carries a lower infection risk and is increasingly used on repeat.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A negative prostate biopsy can miss cancer because needles sample only a small fraction of the gland. If your PSA keeps rising, your urologist may recommend a repeat — but the approach usually changes. EAU and NICE guidelines recommend an MRI scan first, so the repeat targets suspicious areas rather than sampling randomly.

What do these terms mean?

Sampling error
A biopsy takes cores from different areas of the prostate but covers only a fraction of the total gland. A tumour between the needle tracks will not be detected even when the procedure is performed correctly.
PSA velocity
How fast your PSA level is rising over time. A PSA that keeps climbing after a negative biopsy, rather than stabilising, is one of the main reasons a repeat is considered.
Multiparametric MRI (mpMRI)
A specialist prostate MRI that combines several imaging techniques to identify areas that look structurally abnormal. EAU and NICE guidelines recommend this scan before any repeat biopsy.
MRI-targeted (fusion) biopsy
The MRI images are overlaid on the real-time ultrasound during the procedure, guiding the needle toward the specific area identified on the scan rather than sampling the gland at random.
Saturation biopsy
A method that takes a larger number of cores across the prostate to improve the chance of finding a cancer that earlier biopsies missed. It is usually considered later in the pathway, after MRI-targeted repeat has also been negative.
Transperineal route
Needles inserted through the skin between the scrotum and the anus, rather than through the rectal wall. This approach avoids crossing the bowel wall and significantly reduces infection risk compared with the transrectal approach.

When does a negative biopsy lead to a repeat?

A negative biopsy means no cancer was found in the tissue sampled. It does not confirm the prostate is cancer-free. Your urologist weighs whether the result is reassuring or whether the clinical picture suggests further investigation.

The main reasons for a repeat include a PSA that continues to rise steadily, an mpMRI identifying a suspicious area not sampled the first time, or specific findings on the first biopsy — particularly high-grade prostatic intraepithelial neoplasia (high-grade PIN) or atypical small acinar proliferation (ASAP). Both findings are associated with a meaningfully higher probability of cancer being detected on repeat.

Not every rising PSA leads straight to a repeat biopsy. Active monitoring with regular PSA checks and a repeat MRI is often the more appropriate step first. The timing of any repeat depends on how your PSA is behaving, what the MRI shows, and what you and your urologist decide together.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What is different about a repeat biopsy?

The most important difference is that a repeat biopsy is now guided by MRI results rather than taken as random samples across the gland. EAU and NICE guidelines recommend mpMRI before any repeat so the urologist knows which areas to focus on. This improves the yield of the procedure and reduces unnecessary sampling of tissue that looks normal.

The route is also worth discussing. The transperineal approach — where the needle passes through skin rather than the rectal wall — carries a substantially lower risk of infection. NICE and EAU guidance acknowledges infection, including serious infection requiring hospital admission, as a real complication of the transrectal route, particularly as antibiotic resistance has increased. Which route is used is a clinical decision your urologist will explain.

The number of cores may also increase, especially if MRI has identified a suspicious area. Targeted cores from that area are combined with systematic sampling of the rest of the gland. Repeating exactly the same procedure in the same way after a negative result rarely adds useful information.

Questions about repeat biopsy

Is saturation biopsy the next step after a negative repeat?

Usually not. Saturation biopsy is generally considered when two or more biopsies have been negative but clinical suspicion remains high — for instance, because PSA continues to rise or an MRI still identifies an area of concern. It is not the automatic next step after a single negative result. MRI-targeted repeat is almost always the step between a standard negative biopsy and saturation, because directing the needle toward an identified lesion is more precise than simply increasing core numbers. Your urologist will explain whether saturation is being considered and why it is or is not appropriate at this stage.

How many times can a biopsy be repeated?

There is no fixed upper limit. Each decision depends on how your PSA is behaving, what the MRI shows, your age and health, and whether a further result would change your management. At some point the question becomes whether the risk and discomfort of another procedure is justified by what it is likely to find and whether that finding would alter your treatment plan. Your urologist should explain the reasoning clearly at each stage so you can make an informed decision about whether to proceed.

What does the infection risk mean for me?

After a transrectal biopsy, some patients develop urinary tract infections, and a smaller proportion develop more serious infections requiring hospital treatment. NICE and EAU guidance cites infection — including sepsis — as the most significant serious complication of the transrectal route. Guidance has shifted toward the transperineal approach partly because it eliminates the source of that contamination. Before any repeat biopsy, ask your urologist which route is planned and what antibiotic precautions are in place. If you have had a post-biopsy infection previously, tell your team before the procedure.

Can a second negative result mean the PSA rise has another cause?

Yes. PSA can rise because of benign prostatic enlargement, prostatitis, or other conditions unrelated to cancer. A rising PSA after a negative biopsy does not automatically mean cancer is present. Two negative MRI-targeted biopsies in someone with a slowly rising PSA, a normal-appearing MRI, and a large prostate can reasonably support a recommendation to monitor rather than repeat again. Your urologist will explain whether the overall picture is more consistent with cancer or a benign cause, and what the monitoring plan looks like.

What is the difference between the transrectal and transperineal routes?

The transrectal route passes the needle through the rectal wall, introducing bacteria from the bowel into the bloodstream — the primary source of post-biopsy infection risk. As antibiotic resistance has increased, this route has become a more significant concern, and guidance now favours the transperineal approach for many patients. The transperineal route enters through skin rather than the bowel wall, substantially reducing that risk. It usually requires local anaesthetic or sedation. Ask your urologist which route is planned and what the infection-prevention protocol involves at your centre.

What should I ask at my follow-up appointment?

Bring your PSA results from the past year, or ask the clinic to print the trend before the appointment. Ask to see the MRI report explained in plain terms: which areas look suspicious, and were those areas sampled in the previous biopsy? Ask why a repeat is being recommended now rather than continued monitoring, and what happens if the repeat is also negative. Ask which biopsy route is planned and what the infection risk is. Write the answers down — this is a great deal of information to absorb after an anxious wait, and having it on paper helps when you make decisions at home.

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

My PSA has risen after a negative biopsy. Does that definitely mean cancer?

Not necessarily. PSA can rise because of benign prostatic enlargement, prostatitis, a recent infection, or other causes that are not cancer. A rising PSA after a negative biopsy is a signal to investigate further, not a diagnosis. Your urologist will look at the rate of rise, what your MRI shows, and your overall prostate health before deciding whether a repeat biopsy is the right next step or whether a period of monitoring makes more sense.

How long should I wait before having a repeat biopsy?

There is no single recommended interval — it depends on how your PSA is behaving, what the MRI shows, and your urologist's assessment. NICE and EAU guidance does not set a fixed waiting period; the decision is individualised. If your PSA is rising steadily or an MRI has identified a new area of concern, a repeat may be recommended relatively soon. If both are stable, your urologist may prefer a period of monitoring before recommending another procedure.

What if the MRI before my repeat shows nothing suspicious?

A normal mpMRI before a repeat biopsy is genuinely reassuring, though it does not completely rule out cancer — some low-grade cancers are not visible on MRI. Your urologist will weigh the MRI result against your PSA trend. A normal MRI alongside stable or slowly rising PSA often supports continuing to monitor rather than repeating the biopsy. A normal MRI does not mean follow-up stops; it means the immediate risk of missing something clinically significant is lower.

Will the repeat biopsy be more painful than the first?

Most people find the experience similar. Discomfort depends on the route and the anaesthetic used. Transperineal biopsy is usually performed under local anaesthetic or with sedation, which most people find manageable. Pressure and the sound of the needle device are the most commonly described sensations. Tell your urologist if your first biopsy was particularly uncomfortable so they can plan accordingly.

Is repeat prostate biopsy available at CION?

Yes. Prostate biopsies, including repeat procedures, are performed at CION centres as day care. MRI for pre-biopsy planning is coordinated with partner imaging centres. Your urologist at CION will discuss which approach is appropriate for your situation, including the route planned and the infection-prevention protocol.

What if I choose not to have a repeat biopsy?

That is a decision you can make in discussion with your urologist. Declining a repeat does not mean care stops. Active monitoring with regular PSA measurements and repeat MRI at agreed intervals is a legitimate, guideline-supported approach for many men whose previous biopsy was negative. What matters is that you and your urologist agree on a clear plan, understand what you are watching for, and know at what point the threshold for reconsideration is reached.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation